Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Cumberland Pharmaceuticals Inc. (CPIX) vs Lifecore Biomedical, Inc. (LFCR)

Cumberland Pharmaceuticals Inc. and Lifecore Biomedical, Inc. are both Drug Manufacturers Specialty & Generic companies. Lifecore Biomedical, Inc. is the larger, with a market value of $162.4M against $120.0M — 1.4× the size. Cumberland Pharmaceuticals Inc. grew revenue faster over the last twelve months: 32.0% against −10.0%. Cumberland Pharmaceuticals Inc. has the higher net margin (−26.2% vs −37.5%) and the lower return on invested capital (−34.2% vs −2.80%). Across the 17 metrics below, Cumberland Pharmaceuticals Inc. leads on 10 and Lifecore Biomedical, Inc. on 7.

Valuation

Metric CPIX LFCR Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 2.73 1.32 2.25
P/B 6.66 n/m 1.90
Price to free cash flow 197.97 n/m 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales 2.89 2.73 2.56
Earnings yield (9.33%) (23.10%) (2.99%)
Free cash flow yield 0.51% (3.21%) 0.00%

Profitability

Metric CPIX LFCR Drug Manufacturers Specialty & Generic median
Gross margin 82.80% 26.86% 53.94%
Operating margin (17.39%) (6.89%) 0.00%
Net margin (26.17%) (37.54%) 0.00%
Free cash flow margin 1.38% (4.24%) 0.00%
Return on equity (48.76%) 201.15% (0.40%)
Return on assets (16.70%) (19.32%) (3.32%)
Return on invested capital (34.23%) (2.80%) 0.00%

Growth

Metric CPIX LFCR Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 31.98% (10.03%) 10.01%
EPS growth (last fiscal year) 58.70% (439.33%) —
Revenue growth, 5-year CAGR 3.52% (4.24%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CPIX LFCR Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 11.50 0.05
Current ratio 0.96 3.87 2.31
Net debt to EBITDA (4.58) (15.59) 0.85

Dividend

Metric CPIX LFCR Drug Manufacturers Specialty & Generic median
Dividend yield 2.07% — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric CPIX LFCR Drug Manufacturers Specialty & Generic median
Market cap 120.01m 162.39m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack